Very high-risk prostate cancer: multimodality treatment will be the new frontier
Cent European J Urol
.
2017;70(3):324-325.
doi: 10.5173/ceju.2017.1535.
Epub 2017 Aug 16.
Authors
Davide Campobasso
1
,
Giuseppe Prati
2
,
Antonio Frattini
1
Affiliations
1
Civil Hospital of Guastalla, Urology Unit, AUSL of Reggio Emilia, Italy.
2
Civil Hospital of Guastalla, Oncology Unit, AUSL of Reggio Emilia, Italy.
PMID:
29104799
PMCID:
PMC5656377
DOI:
10.5173/ceju.2017.1535
No abstract available